Literature DB >> 20332408

Setting the RECORD Straight.

Steven E Nissen1.   

Abstract

Mesh:

Substances:

Year:  2010        PMID: 20332408     DOI: 10.1001/jama.2010.333

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  10 in total

1.  'Selling sickness: influence on influence', what constitutes good prescribing in 2010?

Authors:  J W Foppe van Mil; Martine E C van Eijk
Journal:  Pharm World Sci       Date:  2010-05-07

2.  Drug research: marketing before evidence, sales before safety.

Authors:  David Klemperer
Journal:  Dtsch Arztebl Int       Date:  2010-04-23       Impact factor: 5.594

3.  Glucose-lowering therapies and cancer risk: the trials and tribulations of trials and observations.

Authors:  J A Johnson; Y Yasui
Journal:  Diabetologia       Date:  2010-06-04       Impact factor: 10.122

Review 4.  Peroxisome proliferator-activated receptor γ: innate protection from excessive fibrogenesis and potential therapeutic target in systemic sclerosis.

Authors:  Jun Wei; Swati Bhattacharyya; John Varga
Journal:  Curr Opin Rheumatol       Date:  2010-11       Impact factor: 5.006

5.  α-Amylase and α-glucosidase inhibitor effects and pancreatic response to diabetes mellitus on Wistar rats of Ephedra alata areal part decoction with immunohistochemical analyses.

Authors:  Jihene Ben Lamine; Mouhamed Ali Boujbiha; Sabra Dahane; Amal Ben Cherifa; Aida Khlifi; Hassiba Chahdoura; Mouhamed Taher Yakoubi; Salima Ferchichi; Nacer El Ayeb; Lotfi Achour
Journal:  Environ Sci Pollut Res Int       Date:  2019-02-07       Impact factor: 4.223

6.  Cardiovascular safety of exenatide BID: an integrated analysis from controlled clinical trials in participants with type 2 diabetes.

Authors:  Robert Ratner; Jenny Han; Dawn Nicewarner; Irina Yushmanova; Byron J Hoogwerf; Larry Shen
Journal:  Cardiovasc Diabetol       Date:  2011-03-16       Impact factor: 9.951

7.  Why we need easy access to all data from all clinical trials and how to accomplish it.

Authors:  Peter C Gøtzsche
Journal:  Trials       Date:  2011-11-23       Impact factor: 2.279

8.  Idealized PPARγ-Based Therapies: Lessons from Bench and Bedside.

Authors:  Angélica Amorim Amato; Francisco de Assis Rocha Neves
Journal:  PPAR Res       Date:  2012-06-14       Impact factor: 4.964

9.  In vitro and in vivo antidiabetic effect of extracts of Melia azedarach, Zanthoxylum alatum, and Tanacetum nubigenum.

Authors:  Mohammad Faheem Khan; Arun Kumar Rawat; Shahnaaz Khatoon; Mohd Kamil Hussain; Arvind Mishra; Devendra Singh Negi
Journal:  Integr Med Res       Date:  2018-03-27

10.  Updating insights into rosiglitazone and cardiovascular risk through shared data: individual patient and summary level meta-analyses.

Authors:  Joshua D Wallach; Kun Wang; Audrey D Zhang; Deanna Cheng; Holly K Grossetta Nardini; Haiqun Lin; Michael B Bracken; Mayur Desai; Harlan M Krumholz; Joseph S Ross
Journal:  BMJ       Date:  2020-02-05
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.